Research Interests
Inflammatory eye disease
Localized scleroderma
Treatment of JIA
Localized scleroderma
Treatment of JIA
Selected Grants
New CARRA Registry
ResearchPrincipal Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2015 - 2027A Multicenter, Open-Label Trial of Intravenous Golimumab, a Human Anti-TNF¿ Antibody, in Pediatric Subjects With Active Polyarticular Course Juvenile Idiopathic Arthritis Despite Methotrexate Therapy
Clinical TrialPrincipal Investigator · Awarded by Janssen Research & Development, LLC · 2015 - 2023Pilot Study for the Implementation of the CARRA Uveitis Consensus Treatment Plans (CTP)
ResearchPrincipal Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2020 - 2022Implementation of Electronic Health Record Optimization Tools to Capture and Extract CARRA Data
ResearchPrincipal Investigator · Awarded by Childhood Arthritis & Rheumatology Research Alliance, Inc. · 2020 - 2021A randomized, double-blind, placebo-controlled, multicenter, phase 3 efficacy and safety study of 2 dose levels of subcutaneious anakinra in patients with Still's disease
Clinical TrialPrincipal Investigator · Awarded by SOBI · 2017 - 2020An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered with Subcutaneous (SC) Injection, in Children and Adolescents, Aged 1 to 17 Years, with Systemic Juvenile Idiopathic Arthritis (sJIA), Followed by an Extensi
Clinical TrialPrincipal Investigator · Awarded by Sanofi US · 2017 - 2020An Open-label, Sequential, Ascending, Repeated Dose-finding Study of Sarilumab, Administered with Subcutaneous (SC) Injection, in Children and Adolescents, Aged 2 to 17 Years, with Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA) Followed b
Clinical TrialPrincipal Investigator · Awarded by Sanofi US · 2017 - 2020Long-Term Extension Study to Evaluate the Safety and Efficacy of Subcutaneous Tocilizumab in Patients with Polyarticular-Course adn Systemic Juvenile Idiopathic Arthritis
Clinical TrialPrincipal Investigator · Awarded by Genentech, Inc. · 2014 - 2018Training Program in Inflammatory and Immunological Diseases
Inst. Training Prgm or CMEPreceptor · Awarded by National Institutes of Health · 1980 - 2017Enhancing Clinical Meaningfulness and Usefulness of PROMIS Pediatric Measures Via Validation in Children and Adolescents with Rheumatic Disease, Cancer of Inflammatory Bowel Disease
ResearchPrincipal Investigator · Awarded by University of North Carolina - Chapel Hill · 2016 - 2017WA28118: Tocilizumab in Systemic JIA
Clinical TrialPrincipal Investigator · Awarded by Genentech, Inc. · 2013 - 2016CARRA Registry Continuation
ResearchPrincipal Investigator · Awarded by Arthritis Foundation · 2015 - 2015IDENTIFICATION OF VUR GENES BY COMBINED LINKAGE ANALYSIS AND EXOME SEQUENCING
ResearchInvestigator · Awarded by National Institutes of Health · 2013 - 2015WA28117: Tocilizumab in Polyarticular-Course JIA
Clinical TrialPrincipal Investigator · Awarded by Genentech, Inc. · 2013 - 2015External Relationships
- American College of Rheumatology
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.